To further confirm this possibility, we pre-incubated the sera of COVID-19 patients with S1-RBD or nucleocapsid recombinant proteins in this study, and found that the effect of inhibiting dengue infection by COVID-19 patients’ sera could be reduced after preincubation with S1-RBD but not nucleocapsid protein. This evidence concerns the gene PSMD1 and COVID-19.